Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005

BACKGROUND: The cysteinyl leukotrienes (LTC4, LTD4 and LTE4) have been implicated in the pathogenesis of allergen-induced airway responses. The effects of pretreatment with BAYx 1005, an inhibitor of leukotriene biosynthesis via antagonism of 5-lipoxygenase activating protein, on allergen-induced ea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hamilton, A. L., Watson, R. M., Wyile, G., O'Byrne, P. M.
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 1997
Assuntos:
Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1758536/
https://ncbi.nlm.nih.gov/pubmed/9196518
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares